- Home
- LSBK vs CTOR Comparison
LSBK vs CTOR Comparison
Compare LSBK & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- CTOR
- Stock Information
- Founded
- LSBK 1891
- CTOR 2021
- Country
- LSBK United States
- CTOR United States
- Employees
- LSBK N/A
- CTOR N/A
- Industry
- LSBK Savings Institutions
- CTOR
- Sector
- LSBK Finance
- CTOR
- Exchange
- LSBK Nasdaq
- CTOR NYSE
- Market Cap
- LSBK 78.8M
- CTOR 89.9M
- IPO Year
- LSBK 2006
- CTOR N/A
- Fundamental
- Price
- LSBK $13.73
- CTOR $1.27
- Analyst Decision
- LSBK
- CTOR Strong Buy
- Analyst Count
- LSBK 0
- CTOR 2
- Target Price
- LSBK N/A
- CTOR $4.50
- AVG Volume (30 Days)
- LSBK 908.0
- CTOR 171.0K
- Earning Date
- LSBK 01-29-2025
- CTOR 02-21-2025
- Dividend Yield
- LSBK 5.24%
- CTOR N/A
- EPS Growth
- LSBK N/A
- CTOR N/A
- EPS
- LSBK 0.74
- CTOR N/A
- Revenue
- LSBK $25,338,000.00
- CTOR N/A
- Revenue This Year
- LSBK N/A
- CTOR N/A
- Revenue Next Year
- LSBK N/A
- CTOR N/A
- P/E Ratio
- LSBK $18.50
- CTOR N/A
- Revenue Growth
- LSBK N/A
- CTOR N/A
- 52 Week Low
- LSBK $13.73
- CTOR $0.85
- 52 Week High
- LSBK $14.21
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- LSBK 58.03
- CTOR N/A
- Support Level
- LSBK $13.22
- CTOR N/A
- Resistance Level
- LSBK $13.51
- CTOR N/A
- Average True Range (ATR)
- LSBK 0.07
- CTOR 0.00
- MACD
- LSBK 0.04
- CTOR 0.00
- Stochastic Oscillator
- LSBK 69.23
- CTOR 0.00
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.